LeMaitre Story

<div class='circular--portrait' style='background:#000000;color: #f2f2f2;font-size:4em;'>LV</div>
LMAT -- USA Stock  

USD 33.98  0.12  0.35%

It appears LeMaitre Vascular will continue to recover much faster as its share price surged up 10.30% today. LeMaitre Vascular's current daily volatility is 4.14 percent, with a beta of 1.21 and an alpha of 0.14 over DOW. While some of us are getting more passionate about medical equipment, it makes sense to review LeMaitre Vascular in greater detail to make a better estimate of its volatility. Why are we still confident in our projection for a recovery.
Published over two months ago
View all stories for LeMaitre Vascular | View All Stories
Should you short LeMaitre after the newest volatility reset?
LeMaitre Vascular currently holds roughly 30.63 M in cash with 15.59 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.52. Our trade recommendations module can be used to complement LeMaitre Vascular advice provided by average analyst sentiment. It analyzes the firm's potential to grow using fundamental, technical, data market data available at this particular time.
Investing in LeMaitre Vascular, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding LeMaitre Vascular along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.

How important is LeMaitre Vascular's Liquidity

LeMaitre Vascular financial leverage refers to using borrowed capital as a funding source to finance LeMaitre Vascular ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. LeMaitre Vascular financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between LeMaitre Vascular's total debt and its cash.

How LeMaitre utilizes its cash?

To perform a cash flow analysis of LeMaitre Vascular, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash LeMaitre Vascular is receiving and how much cash it distributes out in a given period. The LeMaitre Vascular cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. LeMaitre Vascular Net Cash Flow from Operations is comparatively stable at the moment as compared to the past year. LeMaitre Vascular reported Net Cash Flow from Operations of 14.18 Million in 2019

LeMaitre Vascular Correlation with Peers

Investors in LeMaitre can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in LeMaitre Vascular. Diversification will allow for the same portfolio return with reduced risk. The correlation table of LeMaitre Vascular and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities LeMaitre is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage. Please check volatility of LeMaitre for more details

Breaking down the case for LeMaitre Vascular

LeMaitre Vascular appears to be not too volatile, given 1 month investment horizon. LeMaitre Vascular has Sharpe Ratio of 0.0515, which conveys that the firm had 0.0515% of return per unit of volatility over the last month. Our outlook to estimating the volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for LeMaitre Vascular, which you can use to evaluate future volatility of the firm. Please exercise LeMaitre Vascular risk adjusted performance of 0.1448, and Mean Deviation of 2.96 to check out if our risk estimates are consistent with your expectations.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Are LeMaitre Vascular technical ratios showing a correction?

LeMaitre Vascular newest semi variance boosts over 11.55. LeMaitre Vascular shows above-average downside volatility for the selected time horizon. We advise investors to inspect LeMaitre Vascular further and ensure that all market timing and asset allocation strategies are consistent with the estimation of LeMaitre Vascular future alpha.

Our Conclusion on LeMaitre Vascular

Whereas some other companies within the medical instruments & supplies industry are still a little expensive, even after the recent corrections, LeMaitre Vascular may offer a potential longer-term growth to private investors. With a somewhat neutral outlook on your 30 days horizon, it may be better to hold off any trading activity and neither buy new shares of LeMaitre nor trade your existing holdings in the Stock. It seems the expected volatility has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to LeMaitre Vascular.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of LeMaitre Vascular. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com